Escalated M-VAC chemotherapy and recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) in patients with advanced urothelial tract tumors-Reference-Cited by-同舟云学术

Escalated M-VAC chemotherapy and recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) in patients with advanced urothelial tract tumors

Published:1993-05 Issue:5 Volume:4 Page:403-407
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Sternberg C.N.,de Mulder P.H.M.,van Oosterom A.T.,Fossa S.D.,Giannarelli D.,Soedirman J.R.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/4/5/403/342429/4-5-403.pdf

Reference19 articles.

1. M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothehum;Sternberg;J Urol,1988

2. M-VAC for advanced transitional cell carcinoma of the urothelium: Efficacy and patterns of response;Sternberg;Cancer,1989

3. Management of invasive bladder neoplasms;Sternberg,1989

4. The importance of dose intensity in the outcome of chemotherapy;Hryniuk,1988

5. Granulocyte colony stimulating factor and granulocyte macrophage colony stimulating factor;Lieschke;N Engl J Med,1992

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Zymosan A Improved Doxorubicin‐Induced Ventricular Remodeling by Evoking Heightened Cardiac Inflammatory Responses and Healing in Mice;Journal of the American Heart Association;2023-09-19

2. Systemic Chemotherapy in Muscle Invasive and Metastatic Bladder Cancer: Present and Future;Urologia Journal;2017-06-14

3. Efficacy and safety of dose-dense chemotherapy in urothelial carcinoma;Oncotarget;2017-03-31

4. Evaluating the association of multiple single nucleotide polymorphisms with response to gemcitabine and platinum combination chemotherapy in urothelial carcinoma of the bladder;Int. Journal of Clinical Pharmacology and Therapeutics;2017-03-01

5. Neoadjuvant induction dose-dense MVAC for muscle invasive bladder cancer: efficacy and safety compared with classic MVAC and gemcitabine/cisplatin;World Journal of Urology;2015-07-17